ArticleMaterials (Basel, Switzerland)2022
Alkali-silica Reaction Elimination Potential of High-Performance Concrete Containing Glass Powder.
Article in Materials (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
This study is mainly concerned with the assumption that glass powder can eliminate the potential alkali-silica reaction in high performance concrete. Glass is often land filled, produced as a secondary raw material or as a by-product of production. Chemical analyses were carried out, and the ecotoxicity of the material was investigated, serving as a basis for testing a potential alkali-silica reaction. High performance concrete (HPC) containing different types of waste powder (secondary raw material from production (SGP), jewelry production (SGJ), container waste glass (CWG), and glass from used photovoltaic panels (GPP)) are tested according to the international standard ASTM C1260 and the Czech technical condition TP 137. Newly designed mixtures are innocuous from the ASR point of view in the most cases, except SGP HPC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.